Equities

JMS Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7702:TYO

JMS Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)442.00
  • Today's Change-5.00 / -1.12%
  • Shares traded33.20k
  • 1 Year change-7.34%
  • Beta0.5510
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Company’s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.

  • Revenue in JPY (TTM)66.09bn
  • Net income in JPY-224.00m
  • Incorporated1947
  • Employees5.47k
  • Location
    JMS Co Ltd12-17, Kako-cho, Naka-kuHIROSHIMA-SHI 730-8652JapanJPN
  • Phone+81 822435844
  • Fax+81 822435997
  • Websitehttps://www.jms.cc/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Leoclan Co Ltd21.49bn152.78m5.80bn155.0038.811.0322.200.270125.2525.253,629.27951.552.00397.095.36138,642,100.001.602.342.634.7812.7611.260.7991.202.23--0.001234.118.51-0.465612.294.8012.954.98
Data Horizon Co Ltd5.18bn-2.30bn6.14bn367.00--20.34--1.19-181.31-181.31407.7923.740.746621.802.4414,102,500.00-33.20---54.27--36.77---44.47--1.29-3.050.9424--------------
Precision System Science Co Ltd4.93bn-119.23m6.61bn151.00--1.7157.901.34-4.33-4.33180.08140.170.88232.206.4532,653,930.00-2.13-4.14-2.94-5.5529.1430.20-2.42-6.051.50-1.020.1602--17.91-1.5277.43---25.44--
Aso International Inc3.88bn470.10m7.25bn310.0015.692.4714.131.8747.1647.16389.31299.861.2416.267.6612,519,540.0014.96--16.69--45.12--12.11--7.0149.710.00--7.10--13.50------
Yamashita Health Care Holdings Inc63.77bn412.00m9.11bn613.0021.530.998314.240.1429165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m9.68bn321.0010.550.67577.430.8162179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
JTEC Corp1.93bn45.31m10.34bn76.00227.783.8850.245.377.697.69326.97450.770.56051.7126.4925,335,010.001.321.761.491.9961.0259.572.353.782.5519.790.15410.00-4.2213.39-69.7629.84-17.34--
Kainos Laboratories Inc5.46bn597.66m10.38bn157.0016.061.3514.861.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
JMS Co Ltd66.09bn-224.00m11.06bn5.47k--0.26254.610.1673-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
Create Medic Co Ltd13.57bn762.91m11.16bn1.00k13.190.61998.350.822487.6087.601,563.181,863.230.71481.824.9413,545,480.004.023.044.543.5844.6244.515.624.635.1741.710.045860.323.533.74445.963.0114.010.00
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.18bn538.00--0.522424.420.5363-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
OLBA Healthcare Holdings Inc124.48bn1.43bn13.22bn1.39k8.771.056.330.1062241.07241.0721,003.792,008.322.7716.234.8089,362,800.003.173.439.9111.3911.2611.491.151.220.958266.630.225530.513.492.61-4.6834.3828.7114.87
DVx Inc55.33bn308.75m13.28bn334.0041.821.4812.290.2429.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
Daiken Medical Co Ltd10.17bn981.12m15.28bn180.0014.051.7912.441.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn16.25bn985.0013.850.87483.660.484238.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Data as of Feb 13 2026. Currency figures normalised to JMS Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

6.70%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 08 Jan 2026571.40k2.31%
Amova Asset Management Co., Ltd.as of 09 Jan 2026305.80k1.24%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025256.70k1.04%
Dimensional Fund Advisors LPas of 08 Jan 2026253.32k1.02%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 2026118.80k0.48%
BlackRock Japan Co. Ltd.as of 08 Jan 202654.00k0.22%
Asset Management One Co., Ltd.as of 08 Jan 202628.90k0.12%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 08 Jan 202626.90k0.11%
Dimensional Fund Advisors Ltd.as of 30 Nov 202525.20k0.10%
Nissay Asset Management Corp.as of 20 Nov 202416.60k0.07%
More ▼
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.